Steven W. Warmann
YOU?
Author Swipe
View article: Genotype-phenotype correlation and management of Megacystis-Microcolon-Intestinal Hypoperistalsis Syndrome: a descriptive cohort study
Genotype-phenotype correlation and management of Megacystis-Microcolon-Intestinal Hypoperistalsis Syndrome: a descriptive cohort study Open
View article: Minimally invasive surgery in paediatric nephroblastoma
Minimally invasive surgery in paediatric nephroblastoma Open
View article: [68Ga] labelled Exendin for radioguided surgery of intrapancreatic insulin producing lesions in patients with congenital hyperinsulinism
[68Ga] labelled Exendin for radioguided surgery of intrapancreatic insulin producing lesions in patients with congenital hyperinsulinism Open
Background Congenital hyperinsulinism (CHI) is a life threatening disease. Localization of affected intrapancreatic beta cells responsible for focal forms during surgery can be challenging. In this study we investigated a new radioguided s…
View article: Renal Autotransplantation for Resection of Bilateral Nephroblastoma and High-Risk Neuroblastoma in Children
Renal Autotransplantation for Resection of Bilateral Nephroblastoma and High-Risk Neuroblastoma in Children Open
Background/Objectives: In bilateral nephroblastoma and high-risk neuroblastoma in children with extensive tumor involvement of the renal vessels or pedicle, complete tumor resection with preservation of healthy renal tissue is not feasible…
View article: Impact of COVID‐19 on paediatric chronic intestinal failure: A tertiary care children's hospital experience
Impact of COVID‐19 on paediatric chronic intestinal failure: A tertiary care children's hospital experience Open
Objectives Paediatric patients with intestinal failure (IF) are at risk for both gastrointestinal (GI) and systemic complications, thus depending on a functioning network of multidisciplinary care. Data on the clinical impact of coronaviru…
View article: How to improve initial diagnostic accuracy of kidney tumours in childhood?—A non‐invasive approach
How to improve initial diagnostic accuracy of kidney tumours in childhood?—A non‐invasive approach Open
Non‐invasive differentiation of paediatric kidney tumours is particularly important in the SIOP‐RTSG protocols, which recommend pre‐operative chemotherapy without histological confirmation. The identification of clinical and tumour‐related…
View article: Trap-Door Thoracotomy and Clamshell Thoracotomy as Surgical Approaches for Neuroblastoma and Other Thoracic Tumors in Children
Trap-Door Thoracotomy and Clamshell Thoracotomy as Surgical Approaches for Neuroblastoma and Other Thoracic Tumors in Children Open
Solid tumors of the cervicothoracic junction, the posterior mediastinum, or bilateral dorsal thoracic tumors represent a challenge in pediatric surgical oncology. The aim of this study was to evaluate trap-door thoracotomy and clamshell th…
View article: Local MRI before and after Tumor Resection in Neuroblastoma: Impact of Residual Disease on Event Free Survival
Local MRI before and after Tumor Resection in Neuroblastoma: Impact of Residual Disease on Event Free Survival Open
(1) Background: The study aimed to investigate the influence of MRI-defined residual disease on local tumor control after resection of neuroblastic tumors in patients without routine adjuvant radiotherapy. (2) Methods: Patients, who underw…
View article: <scp> <i>TRIM28</i> </scp> inactivation in epithelial nephroblastoma is frequent and often associated with predisposing <scp> <i>TRIM28</i> </scp> germline variants
<span> <i>TRIM28</i> </span> inactivation in epithelial nephroblastoma is frequent and often associated with predisposing <span> <i>TRIM28</i> </span> germline variants Open
Wilms tumors (WTs) are histologically diverse childhood cancers with variable contributions of blastema, stroma, and epithelia. A variety of cancer genes operate in WTs, including the tripartite‐motif‐containing‐28 gene ( TRIM28 ). Case re…
View article: Solid pseudopapillary neoplasms of the pancreas in childhood and adolescence—an analysis of the German Registry for Rare Pediatric Tumors (STEP)
Solid pseudopapillary neoplasms of the pancreas in childhood and adolescence—an analysis of the German Registry for Rare Pediatric Tumors (STEP) Open
Solid pseudopapillary neoplasms (SPNs) are the most common entity among pediatric pancreatic tumors. Still, these are rare tumors with an annual incidence of 0.1–0.2/1,000,000, and little is known about their optimal treatment. This analys…
View article: Combined Metabolic and Functional Tumor Volumes on [18F]FDG-PET/MRI in Neuroblastoma Using Voxel-Wise Analysis
Combined Metabolic and Functional Tumor Volumes on [18F]FDG-PET/MRI in Neuroblastoma Using Voxel-Wise Analysis Open
Purpose: The purpose of our study was to evaluate the association between the [18F]FDG standard uptake value (SUV) and the apparent diffusion coefficient (ADC) in neuroblastoma (NB) by voxel-wise analysis. Methods: From our prospective obs…
View article: Image‐defined risk factors in localized thoracic neuroblastoma and ganglioneuroma
Image‐defined risk factors in localized thoracic neuroblastoma and ganglioneuroma Open
Background The pretreatment International Neuroblastoma Risk Group Staging System (INRGSS) discriminates localized tumors L1/L2 depending on the absence/presence of image‐defined risk factors (IDRFs) at diagnosis. Referring to this new sta…
View article: The role of surgery in the treatment of neuroblastoma metastases at rare sites
The role of surgery in the treatment of neuroblastoma metastases at rare sites Open
Purpose Treatment of neuroblastoma metastases usually consists of chemotherapy and irradiation. However, in selected cases, surgical treatment is also indicated. In this study, we present three cases of patients with neuroblastoma metastas…
View article: Nephron sparing surgery and surgical management of intravascular extension of Wilms tumor
Nephron sparing surgery and surgical management of intravascular extension of Wilms tumor Open
Although general treatment approaches for Wilms tumor differ between Children's Oncology Group and Société Internationale d'Oncologie Pédiatrique‐Renal Tumors Study Group protocols, complex tumors that may be candidates for nephron sparing…
View article: Supplemental Figure legends from Inducing Differentiation of Premalignant Hepatic Cells as a Novel Therapeutic Strategy in Hepatocarcinoma
Supplemental Figure legends from Inducing Differentiation of Premalignant Hepatic Cells as a Novel Therapeutic Strategy in Hepatocarcinoma Open
Figure legends
View article: Effects of doxorubicin and hCXCL8 on stem associated markers in hHCC cell lines from Inducing Differentiation of Premalignant Hepatic Cells as a Novel Therapeutic Strategy in Hepatocarcinoma
Effects of doxorubicin and hCXCL8 on stem associated markers in hHCC cell lines from Inducing Differentiation of Premalignant Hepatic Cells as a Novel Therapeutic Strategy in Hepatocarcinoma Open
Supplemental Figure 6 data file
View article: Data from Inducing Differentiation of Premalignant Hepatic Cells as a Novel Therapeutic Strategy in Hepatocarcinoma
Data from Inducing Differentiation of Premalignant Hepatic Cells as a Novel Therapeutic Strategy in Hepatocarcinoma Open
Hepatocellular carcinoma (HCC) represents the second leading cause of cancer-related deaths and is reported to be resistant to chemotherapy caused by tumor-initiating cells. These tumor-initiating cells express stem cell markers. An accumu…
View article: The mTORC1 pathway in Cul3/p53 ko cells from Inducing Differentiation of Premalignant Hepatic Cells as a Novel Therapeutic Strategy in Hepatocarcinoma
The mTORC1 pathway in Cul3/p53 ko cells from Inducing Differentiation of Premalignant Hepatic Cells as a Novel Therapeutic Strategy in Hepatocarcinoma Open
Supplemental Figure 3 data file
View article: Effects of single or combinational doxorubicin treatment in Cul3/p53 ko cells from Inducing Differentiation of Premalignant Hepatic Cells as a Novel Therapeutic Strategy in Hepatocarcinoma
Effects of single or combinational doxorubicin treatment in Cul3/p53 ko cells from Inducing Differentiation of Premalignant Hepatic Cells as a Novel Therapeutic Strategy in Hepatocarcinoma Open
Supplemental Figure 4 data file
View article: Characterization of CD34+ and CD34- cells from Inducing Differentiation of Premalignant Hepatic Cells as a Novel Therapeutic Strategy in Hepatocarcinoma
Characterization of CD34+ and CD34- cells from Inducing Differentiation of Premalignant Hepatic Cells as a Novel Therapeutic Strategy in Hepatocarcinoma Open
Supplemental Figure 1 data file
View article: Data from Inducing Differentiation of Premalignant Hepatic Cells as a Novel Therapeutic Strategy in Hepatocarcinoma
Data from Inducing Differentiation of Premalignant Hepatic Cells as a Novel Therapeutic Strategy in Hepatocarcinoma Open
Hepatocellular carcinoma (HCC) represents the second leading cause of cancer-related deaths and is reported to be resistant to chemotherapy caused by tumor-initiating cells. These tumor-initiating cells express stem cell markers. An accumu…
View article: Supplemental Material and Methods from Inducing Differentiation of Premalignant Hepatic Cells as a Novel Therapeutic Strategy in Hepatocarcinoma
Supplemental Material and Methods from Inducing Differentiation of Premalignant Hepatic Cells as a Novel Therapeutic Strategy in Hepatocarcinoma Open
detailed information to material and Methods
View article: Effects of doxorubicin and hCXCL8 on stem associated markers in hHCC cell lines from Inducing Differentiation of Premalignant Hepatic Cells as a Novel Therapeutic Strategy in Hepatocarcinoma
Effects of doxorubicin and hCXCL8 on stem associated markers in hHCC cell lines from Inducing Differentiation of Premalignant Hepatic Cells as a Novel Therapeutic Strategy in Hepatocarcinoma Open
Supplemental Figure 6 data file
View article: Differentiation stain using immunofluorescence from Inducing Differentiation of Premalignant Hepatic Cells as a Novel Therapeutic Strategy in Hepatocarcinoma
Differentiation stain using immunofluorescence from Inducing Differentiation of Premalignant Hepatic Cells as a Novel Therapeutic Strategy in Hepatocarcinoma Open
Supplemental Figure 2 data file
View article: Effects of single or combinational doxorubicin treatment in Cul3/p53 ko cells from Inducing Differentiation of Premalignant Hepatic Cells as a Novel Therapeutic Strategy in Hepatocarcinoma
Effects of single or combinational doxorubicin treatment in Cul3/p53 ko cells from Inducing Differentiation of Premalignant Hepatic Cells as a Novel Therapeutic Strategy in Hepatocarcinoma Open
Supplemental Figure 4 data file
View article: Doxorubicin treatments (raw data) in human HCC cell lines from Inducing Differentiation of Premalignant Hepatic Cells as a Novel Therapeutic Strategy in Hepatocarcinoma
Doxorubicin treatments (raw data) in human HCC cell lines from Inducing Differentiation of Premalignant Hepatic Cells as a Novel Therapeutic Strategy in Hepatocarcinoma Open
Supplemental Figure 5 data file
View article: Characterization of CD34+ and CD34- cells from Inducing Differentiation of Premalignant Hepatic Cells as a Novel Therapeutic Strategy in Hepatocarcinoma
Characterization of CD34+ and CD34- cells from Inducing Differentiation of Premalignant Hepatic Cells as a Novel Therapeutic Strategy in Hepatocarcinoma Open
Supplemental Figure 1 data file
View article: Doxorubicin treatments (raw data) in human HCC cell lines from Inducing Differentiation of Premalignant Hepatic Cells as a Novel Therapeutic Strategy in Hepatocarcinoma
Doxorubicin treatments (raw data) in human HCC cell lines from Inducing Differentiation of Premalignant Hepatic Cells as a Novel Therapeutic Strategy in Hepatocarcinoma Open
Supplemental Figure 5 data file
View article: The mTORC1 pathway in Cul3/p53 ko cells from Inducing Differentiation of Premalignant Hepatic Cells as a Novel Therapeutic Strategy in Hepatocarcinoma
The mTORC1 pathway in Cul3/p53 ko cells from Inducing Differentiation of Premalignant Hepatic Cells as a Novel Therapeutic Strategy in Hepatocarcinoma Open
Supplemental Figure 3 data file
View article: Supplemental Figure legends from Inducing Differentiation of Premalignant Hepatic Cells as a Novel Therapeutic Strategy in Hepatocarcinoma
Supplemental Figure legends from Inducing Differentiation of Premalignant Hepatic Cells as a Novel Therapeutic Strategy in Hepatocarcinoma Open
Figure legends